{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:50:56Z","timestamp":1785898256262,"version":"3.56.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis","award":["LymphoC HC013"],"award-info":[{"award-number":["LymphoC HC013"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162965","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T17:32:11Z","timestamp":1476725531000},"page":"e0162965","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study"],"prefix":"10.1371","volume":"11","author":[{"given":"Laurent","family":"Alric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Jeannel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Michot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Canioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Davi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Rabiega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Ysebaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","article-title":"Influence of antiviral therapy in hepatitis C virus associated cryoglobulinemic MPGN","volume":"43","author":"L Alric","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","article-title":"Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH","volume":"31","author":"A Nieters","year":"2006","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.23889","article-title":"Antiviral therapy is associated with better survival in patients with hepatitis C virus and B-cell non-hodgkin lymphomas, ANRS HC-13 lympho-C study","volume":"90","author":"JM Michot","year":"2015","journal-title":"Am J hematol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs","volume":"24","author":"C Besson","year":"2006","journal-title":"J clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"O Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2014.03.051","article-title":"Effectiveness of telaprevir or boceprevir in treatment experienced patients with HCV genotype 1 infection and cirrhosis","volume":"147","author":"C Hezode","year":"2014","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, mmanaging, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2014.08.015","article-title":"PegIFN alpha\/ribavirin\/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemie vasculitis","volume":"62","author":"D Saadoun","year":"2015","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low grade, B-cell, non-hodgkin\u2019s lymphoma: a multicenter Italian experience","volume":"23","author":"D Vallisa","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref10","first-page":"74","article-title":"Splenic lymphoma with villous lymphocytes associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"D Saadoun","year":"2005","journal-title":"Bood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"BD Cheson","year":"2007","journal-title":"J clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jmv.21976","article-title":"Influence of HCV genotype on the virus response to PEG interferon alpha 2 plus ribavirin therapy","volume":"83","author":"F Nicot","year":"2001","journal-title":"J Med Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4254\/wjh.v6.i9.660","article-title":"Telaprevir and boceprevir based tritherapis in real practice for F3-F4 pretreated hepatitis C virus patients","volume":"6","author":"D Bonnet","year":"2014","journal-title":"World J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"ref15","first-page":"490","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"V Agnelle","year":"1992","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002281-200201000-00006","article-title":"Cryoglobulinemia vasculitis","volume":"14","author":"P Cacoub","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 84 cases and 6269 controls from the International Lymphoma Apidemiology Consortium","volume":"6","author":"S De Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","first-page":"01203","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","author":"F Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V87.10.4296.bloodjournal87104296","article-title":"Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders","volume":"87","author":"F Silvestri","year":"1996","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ijc.20021","article-title":"Hepatitis C virus infection and non-Hogkin lymphoma: results of the NCI-SEER multi center case-control study","volume":"111","author":"EA Engels","year":"2004","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2008.06.025","article-title":"Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin\u2019s lumphoma","volume":"49","author":"VL Mura","year":"2008","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"L Arcaini","year":"2014","journal-title":"Ann Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.27623","article-title":"Long term effect of HCV eradication in patients with cryoglobulinemia: a prospective controlled open label cohort","volume":"61","author":"L Gragnani","year":"2015","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2014.09.031","article-title":"Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon free, NS3\/NS4A inhibitor-based treatment. A case report","volume":"62","author":"R Rossotti","year":"2015","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2014-12-618652","article-title":"Regression of HCV associated disseminated marginal zone lymphoma under IFN free antiviral treatment","volume":"125","author":"P Sultanik","year":"2015","journal-title":"Blood"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T18:25:58Z","timestamp":1601144758000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162965"}},"subtitle":[],"editor":[{"given":"Ming-Lung","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162965","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,17]]}}}